Table 2. Crude incidence rates of outcomes.

						CHA2DS2-VASc scores
		Total				0–2				3–4				5–6				7–9
Subgroup		N	py	E	IR*	N	py	E	IR*	N	py	E	IR*	N	py	E	IR*	N	py	E	IR*
All cancers
All patients		5130	16688	330	19.77	1270	4591	64	13.94	1716	5810	129	22.2	1436	4384	98	22.35	708	1903	39	20.5
Gender	Female	2381	7799	109	13.98	276	1046	9	8.61	777	2761	36	13.04	816	2553	45	17.63	512	1439	19	13.2
	Male	2749	8889	221	24.86	994	3545	55	15.51	939	3049	93	30.5	620	1831	53	28.94	196	463	20	43.16
Age	<65	1395	5257	55	10.46	901	3381	35	10.35	403	1562	12	7.68	82	293	7	23.9	9	22	1	46.32
	65–74	1268	4330	109	25.17	274	925	22	23.78	573	1970	55	27.91	340	1181	26	22.02	81	254	6	23.65
	75+	2467	7101	166	23.38	95	285	7	24.56	740	2278	62	27.22	1014	2910	65	22.33	618	1628	32	19.66
By type of cancer
Breast cancer		2381	7799	12	1.54	276	1046	2	1.91	777	2761	4	1.45	816	2553	4	1.57	512	1439	2	1.39
Colon cancer		5130	16688	55	3.3	1270	4591	10	2.18	1716	5810	25	4.3	1436	4384	10	2.28	708	1903	10	5.26
Liver cancer		5130	16688	35	2.1	1270	4591	6	1.31	1716	5810	15	2.58	1436	4384	9	2.05	708	1903	5	2.63
Lung cancer		5130	16688	58	3.48	1270	4591	15	3.27	1716	5810	21	3.61	1436	4384	19	4.33	708	1903	3	1.58

* per 1000 person-years

Abbreviations: N, patient no.; py, person year; E, event no.; IR, incidence rate